glp 1 drugs sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it Sex Drive, Erectile Dysfunction, and

The National Weight Control Registry, which tracks individuals who have successfully maintained significant weight loss, identifies common characteristics including high levels of physical activity, regular breakfast consumption, consistent eating patterns across weekdays and weekends, and frequent self-weighing

Decreased Adipose Tissue Oxygenation Associates with Insulin Resistance in Individuals with Obesity

doi: 10.1055/s-0031-1271777 49 Ben NasrMUsuelliVDellepianeSSeelamAJFiorentinoTVDAddioFet al

GLP-1 receptor agonists: gastric emptying, procedures, and pancreatic safety

In addition, recent studies suggest that GLP-1s may be linked with a rare yet serious condition called nonarteritic anterior ischemic optic neuropathy (NAION)

Importantly, these adverse events were generally mild to moderate in severity and rarely resulted in complications or permanent treatment discontinuation